2008 Program

November 10-12, 2008
Centers for Disease Control and Prevention
Atlanta, Georgia, USA

About BioFusion | Register | Program | Presenters | Sponsors | Venue & Lodging | BioSouth 

What is BioFusion?

In its third year, BioFusion 2008 remains the premier bio-partnering conference for the southern United States and the only such conference organized by a southern-based organization.  Organized by BioSouth, Inc. and its many partners, BioFusion 2008 is designed to foster partnering opportunities among members of the biosciences industry, including pharmaceutical, biotechnology, medical device, biomanufacturing, drug discovery, drug delivery and clinical research companies.  The event also targets research universities and institutions, such as the Center for Disease Control and Prevention (CDC), Duke University, Saint Joseph's Research Institute, Oak Ridge National Laboratory and the Georgia Institute of Technology. 

Leading biosciences companies and institutions committed to attending BioFusion 2008 can combine marketing efforts to secure funding through partnerships, research and development support, technology licensing, new sales and distribution channels and many other opportunities.  The conference will be held November 9th & 10th, 2008, in Atlanta, Georgia, at the Center for Disease Control and Prevention (CDC). 

Who will be there?

§         From start-up to large, multi-national U.S. biosciences companies, to include pharmaceutical, biotechnology and medical device companies

§         Prominent research universities and institutions from across the Southern United States and our international partners

§         Venture Capitalists

§         Regional and international economic development organizations

Who should attend?

CEOs, business development executives and other members of senior management teams; researchers and scientists; technology transfer officers and venture capitalists and other investors working in the biosciences industry

Why Atlanta?

§         Atlanta will host BIO in 2009, one of the largest international biosciences conferences

§         Atlanta is the U.S. home to representatives of BioSouth’s founding international partners, Canada, Germany, Israel and the United Kingdom

§         Atlanta’s business community has a long history of supporting bioscience industry growth and economic development efforts.

Following 2008, BioFusion may rotate among other Southern U.S. cities recognized as leading bioscience centers.

You can contact BioSouth to learn more and receive notification of our plans. To learn about the 2006 conference, feel free to review this website.

Fall conference plans in development. Stay tuned…

 

Read a recent success story published about BioFusion 2006

2006 Program Highlights

September 17-19, 2006
Washington Duke Inn & Golf Club
Research Triangle Park, North Carolina, USA

Conference Highlights:

Headline Sponsors

Merck & Co., Inc.

Centers for Disease Control & Prevention

Manning Selvage & Lee

Emory University

...additional sponsors


Washington Duke Inn & Golf Club

Delegates from across the globe gathered at the beautiful Washington Duke Inn & Golf Club in Durham, North Carolina for the 2nd annual BioFusion partnering conference. As the third largest biotech center in the United States, North Carolina houses over 225 biotech, pharmaceutical, lab testing and contract research organizations and over 50 medical device companies. Along with some of the world's leading research universities, the Research Triangle Park region boasts numerous bioscience innovations and manufacturing resources, all within a 15 minute drive from the site of BioFusion 2006.

Participating Companies Included:

3M
Abeome Corporation
Acordia
Addrenex Pharmaceuticals, Inc.
Aetos Technologies, Inc.
Alston & Bird LLP
Bespak
BioCryst Pharmaceuticals, Inc.
BioQuotient
BioSpace
Biovectra DCL
Business Wire
Calvert Research Institute
Canadian Consulate General
Canadian Consulate--RALDM
Canadian Light Source Inc
Cardinal Health
Castle & Cooke North Carolina LLC
Centers for Disease Control and Prevention
Chimerix Inc.
CIIT Centers for Health Research
Cirrus Pharmaceuticals Inc
CleveMed
Code Refinery
Cognosci, Inc.
Collexis, Inc.
Colliers Pinkard
Constella Group LLC
Copernicus Group IRB
Cordium Links
Council for Entrepreneurial Development (CED)
Cupron, Inc
Daiichi Sankyo Research Institute
Davos Chemical Corporation
Duke University
Eli Lilly and Company
Fish & Richardson PC
Flocel
Genzyme Corporation
Georgia Department of Economic Development
Georgia Medical Center Authority
Georgia State University
GlaxoSmithKline
Global Patent Strategies PLLC
GSK
Harrison Goddard Foote
Hatteras BioCapital
Hunton & Williams
Hutchison Law Group PLLC
IBM
ImmunoBiosciences, Inc.
Intersouth Partners
Kyowa Hakko Kogyo CO., Ltd

Life Science Analytics
LIfe Sciences Innovation Center
Life Therapeutics Limited
Manning Selvage & Lee
MBL International Corporation
Medical Device Marketing, LLC
MedPharm Ltd
Merck & Company, Inc.
Metastatix
Metropolitan Research Associates
Millipore
MS&L
Nabi Biopharmaceuticals
National Research Council of Canada - Institute for Biological
     Sciences
NC Commerce - International Trade
NCBIO
Neurologix, Inc.
O'Brien/Atkins Associates
Optimus Pharmaceuticals
Pappas Ventures
Patheon Inc.
Perlitz Strategy Group-Americas Inc.
Pfizer Inc
Pharmaplan
Pharmasset
Pounce Corporation
Precision BioSciences
PRENSA LIBRE USA
Primagen Inc.
Roche Applied Science
Scripps Florida
Solvay Pharmaceuticals, Inc.
Southeast BIO
Square 1 Bank
St Charles Pharmaceuticals
Stem Cell Innovations, Inc.
Syngenta Biotechnology, Inc.
Syntherica Corporation
The Caraway Management Group, Inc.
The UAB Research Foundation
Thompson Hine, LLP
Tm Bioscience Corporation
Transpharma Medical Ltd.
UAB Research Foundation
UK Trade & Investment
Vanderbilt University

Vertical*i, Inc.
Warwick Effect Polymers Ltd.
Whiting-Turner Contracting Company
Woodcock Washburn LLP
WYNDEN Pharmaceuticals
Yates Construction

 


produced by
BioSouth, Inc.